ID: ALA48242

Max Phase: Preclinical

Molecular Formula: C26H24N6O2

Molecular Weight: 452.52

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): CV-11194
Synonyms from Alternative Forms(1):

    Canonical SMILES:  CCCCc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1

    Standard InChI:  InChI=1S/C26H24N6O2/c1-2-3-11-23-27-22-10-6-9-21(26(33)34)24(22)32(23)16-17-12-14-18(15-13-17)19-7-4-5-8-20(19)25-28-30-31-29-25/h4-10,12-15H,2-3,11,16H2,1H3,(H,33,34)(H,28,29,30,31)

    Standard InChI Key:  FLOKGHWIQFCIJW-UHFFFAOYSA-N

    Associated Targets(non-human)

    Agtr1b Angiotensin II receptor (1735 Activities)
    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
    AGTR1 Angiotensin II type 1a (AT-1a) receptor (440 Activities)
    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
    Rattus norvegicus (775804 Activities)
    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
    AGTR1 Angiotensin II type 1a (AT-1a) receptor (1700 Activities)
    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 452.52Molecular Weight (Monoisotopic): 452.1961AlogP: 4.97#Rotatable Bonds: 8
    Polar Surface Area: 109.58Molecular Species: ACIDHBA: 6HBD: 2
    #RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
    CX Acidic pKa: 1.85CX Basic pKa: 5.86CX LogP: 4.45CX LogD: 1.85
    Aromatic Rings: 5Heavy Atoms: 34QED Weighted: 0.34Np Likeness Score: -1.05

    References

    1. Kubo K, Inada Y, Kohara Y, Sugiura Y, Ojima M, Itoh K, Furukawa Y, Nishikawa K, Naka T..  (1993)  Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazoles.,  36  (12): [PMID:8510105] [10.1021/jm00064a011]
    2. Kubo K, Kohara Y, Imamiya E, Sugiura Y, Inada Y, Furukawa Y, Nishikawa K, Naka T..  (1993)  Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of benzimidazolecarboxylic acids.,  36  (15): [PMID:8340921] [10.1021/jm00067a016]
    3. Kubo K, Kohara Y, Yoshimura Y, Inada Y, Shibouta Y, Furukawa Y, Kato T, Nishikawa K, Naka T..  (1993)  Nonpeptide angiotensin II receptor antagonists. Synthesis and biological activity of potential prodrugs of benzimidazole-7-carboxylic acids.,  36  (16): [PMID:8360879] [10.1021/jm00068a011]
    4. Kohara Y, Kubo K, Imamiya E, Wada T, Inada Y, Naka T..  (1996)  Synthesis and angiotensin II receptor antagonistic activities of benzimidazole derivatives bearing acidic heterocycles as novel tetrazole bioisosteres.,  39  (26): [PMID:8978851] [10.1021/jm960547h]
    5. Naik P, Murumkar P, Giridhar R, Yadav MR..  (2010)  Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective.,  18  (24): [PMID:21071232] [10.1016/j.bmc.2010.10.043]
    6. Jain A, Chaturvedi SC.  (2010)  QSAR modeling of some substituted benzimidazole as Angotensin II AT1 receptor antagonist,  19  (2): [10.1007/s00044-009-9182-z]

    Source